Sung-Hwan Cho
Vorstandsvorsitzender bei CHOA PHARMACEUTICAL CO., LTD.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Sung-Hwan Cho
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CHOA PHARMACEUTICAL CO., LTD. | Direktor/Vorstandsmitglied | 18.02.2002 | - |
Vorstandsvorsitzender | - | - | |
Präsident | - | - | |
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Vorstandsvorsitzender | - | - |
Präsident | - | - |
Karriereverlauf von Sung-Hwan Cho
Ausbildung von Sung-Hwan Cho
Korea University | Undergraduate Degree |
Chung-Ang University | Graduate Degree |
Statistik
International
Südkorea | 5 |
Operativ
President | 2 |
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Börse
- Insiders
- Sung-Hwan Cho
- Erfahrung